Emerging Chemicals of Health Concern in Electronic Nicotine Delivery Systems

Electronic nicotine delivery systems.

treatments in the UK cystic fibrosis population: a longitudinal study. Lancet Respir Med 2013; 1: 121–128. 3 Beker LT, Russek-Cohen E, Fink RJ. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc 2001; 101: 438–442. 4 Fogarty AW, Britton J, Clayton A, et al. Are measures of body habitus associated with mortality in cystic fibrosis? Chest 2012; 142: 712–717. 5 Fogarty AW,...

Electronic nicotine delivery systems: emerging science foundation for policy.

Since they were first marketed in China in 2004, electronic nicotine delivery systems (ENDS) have spread globally like wildfire. Their proponents, who refer to the products as “electronic cigarettes” or “E-cigs”, argue that by delivering nicotine to the lung, they are more effective and acceptable than nicotine replacement medicines, and should be readily available as cigarette substitutes. An ...

Perfluorinated Chemicals: an emerging concern

Electronic nicotine delivery systems: a research agenda.

Electronic nicotine delivery systems (ENDS, also called electronic cigarettes or e-cigarettes) are marketed to deliver nicotine and sometimes other substances by inhalation. Some tobacco smokers report that they used ENDS as a smoking cessation aid. Whether sold as tobacco products or drug delivery devices, these products need to be regulated, and thus far, across countries and states, there ha...

The Potential Adverse Health Consequences of Exposure to Electronic Cigarettes and Electronic Nicotine Delivery Systems.

Tobacco continues to be the leading cause of preventable death and illness in the United States and the world (World Health Organization, 2011). In addition, tobacco is responsible for one in three cancer deaths in the United States (American Cancer Society, 2015). Prevention of tobacco-related disease, disability, and death could be achieved by promoting tobacco control (i.e., preventing uptak...